Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 2,219.00
-48.50 (-2.14%)
May 26, 2026, 11:30 AM JST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 4.06 trillion as of May 22, 2026. Its market cap has increased by 65.88% in one year.
Market Cap
4.06T
Enterprise Value
4.35T
Revenue
2.14T
Ranking
n/a
PE Ratio
13.98
Stock Price
2,219.00
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 4.06T, an increase of 360.13%. That is a compound annual growth rate of 4.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 4.07T | 8.45% |
| Dec 30, 2025 | 3.75T | 36.48% |
| Dec 30, 2024 | 2.75T | -9.13% |
| Dec 29, 2023 | 3.02T | -17.34% |
| Dec 30, 2022 | 3.66T | 5.52% |
| Dec 30, 2021 | 3.47T | 17.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.31T |
| Otsuka Holdings | 6.13T |
| Daiichi Sankyo Company | 4.82T |
| Kyowa Kirin | 1.25T |
| Ono Pharmaceutical | 1.17T |
| Santen Pharmaceutical | 612.80B |
| JCR Pharmaceuticals | 61.73B |
| Perseus Proteomics | 2.57B |